RxDoctor Payments Data

Amanda Powers

Physician Assistant · Utica, NYNPI 1770140204

Payments from drug & device makers

$5,800in general payments, 2019–2025

Across 114 payments — averaging $50.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • Medtronic$2K
  • E.r. Squibb & Sons, L.L.C.$479
  • Abiomed$309
  • Pfizer$304
  • Novartis$236
  • plus $634 from 10 others

What the payments were for

  • Travel & lodging$2,40842%
  • Food & beverage$3,24856%
  • Education$1442%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,800 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$75,532
Medicare patients
560
Services billed
821

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban214$268,488
EntrestoSacubitril/Valsartan195$216,754
JardianceEmpagliflozin73$75,045
XareltoRivaroxaban46$70,669
Repatha SureclickEvolocumab48$35,798
BrilintaTicagrelor13$10,675
Metoprolol Succinate322$6,539
Bisoprolol Fumarate147$4,806
Rosuvastatin Calcium242$3,929
Ranolazine ErRanolazine36$3,342
Amiodarone Hcl64$2,562
Irbesartan39$2,085
Losartan Potassium159$1,821
Atorvastatin Calcium144$1,453
Amlodipine Besylate194$1,330

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$304$268,488214 claims
NovartisEntresto$236$216,754195 claims
Boehringer IngelheimJardiance$159$75,04573 claims
AstraZenecaBrilinta$150$10,67513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Utica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →